Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 3Gastrointestinal 1

Conditions

Ovarian Neoplasms 51Endometrial Neoplasms 21Fallopian Tube Neoplasms 17Sarcoma 9Peritoneal Neoplasms 9Neoplasm Metastasis 7Neoplasms 6Liposarcoma 6Leiomyosarcoma 5Hemangiosarcoma 5Fibrosarcoma 5Carcinoma, Ovarian Epithelial 5Uterine Neoplasms 4Stomach Neoplasms 4Sarcoma, Synovial 4Recurrence 4Neurofibrosarcoma 4Malignant mesenchymal tumor 4Histiocytoma, Malignant Fibrous 4Desmoplastic Small Round Cell Tumor 4Colorectal Neoplasms 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma, Endometrial Stromal 3Rhabdomyosarcoma 3Hemangiopericytoma, Malignant 3Breast Neoplasms 3Appendiceal Neoplasms 3Sarcoma, Alveolar Soft Part 2Pheochromocytoma 2

Interventions

Cisplatin 180Radiotherapy 81Paclitaxel 80Brachytherapy 74Carboplatin 72pembrolizumab 63Bevacizumab 40Surveys and Questionnaires 29Colposcopy 29Radiation 28Gemcitabine 28Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 27Topotecan 26Magnetic Resonance Spectroscopy 24Blood Specimen Collection 23human papillomavirus vaccine, L1 type 16, 18 22Nivolumab 22Drug Therapy 21Papillomavirus Vaccines 20atezolizumab 19Platinum 19Radiotherapy, Intensity-Modulated 18Biopsy 18Docetaxel 17Taxes 16Cyclophosphamide 16Early Intervention, Educational 151,2-diaminocyclohexaneplatinum II citrate 15Methods 14fludarabine 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Doxorubicin × Gynecologic × Clear all
NCT06023862 2026-05-06

DOVE

Yonsei University

Phase 2 Recruiting
198 enrolled
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Adenocarcinoma, Clear Cell

NCT03340376 2024-07-03

Doxorubicin Alone Versus Atezolizumab Alone Versus Doxorubicin and Atezolizumab in Recurrent Cervical Cancer

Universitaire Ziekenhuizen KU Leuven

Phase 2 Active not recruiting
48 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT03604653 2022-08-03

Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers

Holy Name Medical Center, Inc.

Completed
10 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡